vs
Esperion Therapeutics, Inc.（ESPR）与PagerDuty, Inc.（PD）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是PagerDuty, Inc.的1.4倍（$168.4M vs $124.5M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 4.7%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 5.9%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
PagerDuty是一家美国云计算企业，主打面向IT运维部门的SaaS事件管理平台，可帮助企业实时响应运维异常、快速定位并处理故障，保障业务系统稳定运行，目前已成为全球IT运维领域广受认可的数字化解决方案服务商。
ESPR vs PD — 直观对比
营收规模更大
ESPR
是对方的1.4倍
$124.5M
营收增速更快
ESPR
高出139.0%
4.7%
两年增速更快
ESPR
近两年复合增速
5.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $124.5M |
| 净利润 | — | $161.6M |
| 毛利率 | — | 85.3% |
| 营业利润率 | 50.6% | 6.5% |
| 净利率 | — | 129.7% |
| 营收同比 | 143.7% | 4.7% |
| 净利润同比 | — | 2827.7% |
| 每股收益（稀释后） | $0.32 | $1.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRPD
| Q4 25 | $168.4M | $124.5M | ||
| Q3 25 | $87.3M | $123.4M | ||
| Q2 25 | $82.4M | $119.8M | ||
| Q1 25 | $65.0M | $121.4M | ||
| Q4 24 | $69.1M | $118.9M | ||
| Q3 24 | $51.6M | $115.9M | ||
| Q2 24 | $73.8M | $111.2M | ||
| Q1 24 | $137.7M | $111.1M |
净利润ESPRPD
| Q4 25 | — | $161.6M | ||
| Q3 25 | $-31.3M | $9.6M | ||
| Q2 25 | $-12.7M | $-7.2M | ||
| Q1 25 | $-40.5M | $-8.8M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $-29.5M | $-10.9M | ||
| Q2 24 | $-61.9M | $-17.1M | ||
| Q1 24 | $61.0M | $-28.2M |
毛利率ESPRPD
| Q4 25 | — | 85.3% | ||
| Q3 25 | — | 84.6% | ||
| Q2 25 | — | 84.0% | ||
| Q1 25 | — | 83.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | — | 82.7% | ||
| Q2 24 | — | 82.6% | ||
| Q1 24 | — | 81.7% |
营业利润率ESPRPD
| Q4 25 | 50.6% | 6.5% | ||
| Q3 25 | -11.4% | 2.9% | ||
| Q2 25 | 8.6% | -8.6% | ||
| Q1 25 | -34.0% | -9.6% | ||
| Q4 24 | -6.4% | -8.7% | ||
| Q3 24 | -31.0% | -13.8% | ||
| Q2 24 | 3.5% | -19.5% | ||
| Q1 24 | 52.5% | -30.1% |
净利率ESPRPD
| Q4 25 | — | 129.7% | ||
| Q3 25 | -35.9% | 7.8% | ||
| Q2 25 | -15.4% | -6.0% | ||
| Q1 25 | -62.2% | -7.2% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | -57.2% | -9.4% | ||
| Q2 24 | -83.9% | -15.4% | ||
| Q1 24 | 44.3% | -25.3% |
每股收益（稀释后）ESPRPD
| Q4 25 | $0.32 | $1.69 | ||
| Q3 25 | $-0.16 | $0.10 | ||
| Q2 25 | $-0.06 | $-0.07 | ||
| Q1 25 | $-0.21 | $-0.12 | ||
| Q4 24 | $-0.14 | $-0.07 | ||
| Q3 24 | $-0.15 | $-0.14 | ||
| Q2 24 | $-0.33 | $-0.26 | ||
| Q1 24 | $0.34 | $-0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $547.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $320.5M |
| 总资产 | $465.9M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRPD
| Q4 25 | $167.9M | $547.8M | ||
| Q3 25 | $92.4M | $567.9M | ||
| Q2 25 | $86.1M | $597.1M | ||
| Q1 25 | $114.6M | $570.8M | ||
| Q4 24 | $144.8M | $542.2M | ||
| Q3 24 | $144.7M | $599.3M | ||
| Q2 24 | $189.3M | $592.8M | ||
| Q1 24 | $226.6M | $571.2M |
总债务ESPRPD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $484.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $489.5M |
股东权益ESPRPD
| Q4 25 | $-302.0M | $320.5M | ||
| Q3 25 | $-451.4M | $180.7M | ||
| Q2 25 | $-433.5M | $145.7M | ||
| Q1 25 | $-426.2M | $129.8M | ||
| Q4 24 | $-388.7M | $111.6M | ||
| Q3 24 | $-370.2M | $164.7M | ||
| Q2 24 | $-344.2M | $174.0M | ||
| Q1 24 | $-294.3M | $171.6M |
总资产ESPRPD
| Q4 25 | $465.9M | $1.0B | ||
| Q3 25 | $364.0M | $891.5M | ||
| Q2 25 | $347.1M | $926.8M | ||
| Q1 25 | $324.0M | $927.3M | ||
| Q4 24 | $343.8M | $866.8M | ||
| Q3 24 | $314.1M | $916.0M | ||
| Q2 24 | $352.3M | $924.0M | ||
| Q1 24 | $373.1M | $925.3M |
负债/权益比ESPRPD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.73× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.85× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $24.8M |
| 自由现金流经营现金流 - 资本支出 | — | $24.1M |
| 自由现金流率自由现金流/营收 | — | 19.3% |
| 资本支出强度资本支出/营收 | 0.0% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 0.15× |
| 过去12个月自由现金流最近4个季度 | — | $117.6M |
8季度趋势，按日历期对齐
经营现金流ESPRPD
| Q4 25 | $45.2M | $24.8M | ||
| Q3 25 | $-4.3M | $34.0M | ||
| Q2 25 | $-31.4M | $30.7M | ||
| Q1 25 | $-22.6M | $31.4M | ||
| Q4 24 | $-35.0M | $22.1M | ||
| Q3 24 | $-35.3M | $35.8M | ||
| Q2 24 | $-7.2M | $28.6M | ||
| Q1 24 | $53.8M | $22.2M |
自由现金流ESPRPD
| Q4 25 | — | $24.1M | ||
| Q3 25 | — | $33.1M | ||
| Q2 25 | — | $30.2M | ||
| Q1 25 | — | $30.3M | ||
| Q4 24 | — | $21.5M | ||
| Q3 24 | $-35.5M | $35.1M | ||
| Q2 24 | $-7.3M | $28.2M | ||
| Q1 24 | $53.8M | $21.2M |
自由现金流率ESPRPD
| Q4 25 | — | 19.3% | ||
| Q3 25 | — | 26.8% | ||
| Q2 25 | — | 25.2% | ||
| Q1 25 | — | 24.9% | ||
| Q4 24 | — | 18.1% | ||
| Q3 24 | -68.7% | 30.3% | ||
| Q2 24 | -9.9% | 25.4% | ||
| Q1 24 | 39.0% | 19.1% |
资本支出强度ESPRPD
| Q4 25 | 0.0% | 0.6% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.9% |
现金转化率ESPRPD
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 3.55× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
